29Oct 2017

A CASE STUDY ON THE THERAPEUTIC EFFECT OF MALLA SINDOOR AND SHRING BHASMA IN THE ELEVATED ABSOLUTE EOSINOPHIL COUNT.

  • Research Officer (S-2) Regional Ayurveda Research Institute for Drug Development, Aamkho, Gwalior (M.P.).
  • Research Officer-Ay Regional Ayurveda Research Institute for Drug Development, Aamkho, Gwalior (M.P.).
  • Senior Consultant Regional Ayurveda Research Institute for Drug Development, Aamkho, Gwalior (M.P.).
  • Assistant Director, Regional Ayurveda Research Institute for Drug Development, Aamkho, Gwalior (M.P.).
  • Ex-Assistant Director Regional Ayurveda Research Institute for Drug Development, Aamkho, Gwalior (M.P.).
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Allergic rhinitis is one of the most common chronic conditions with a significant impact on the quality of life. The association between eosinophils and allergic disease has been known for many years. Allergic rhinitis patients are at risk of development of Asthma. The patients may also have peripheral eosinophilia and bronchial hyper reactivity. Absolute eosinophil count was correlated with bronchial hyper reactivity. As per Ayurveda, allergic rhinitis is compared with Vata-KaphajaPratishyay. The concept of Ama, Asatamya and ViruddhAahara also predict the allergic conditions. Aims & Objectives:To evaluate the therapeutic effect of MallaSindoorand ShringBhasmain the elevated absolute eosinophil count Materials and Methods: In the present study a 71 year old women presented with clinical features indicative of Allergic rhinitis were examined; a clinical diagnosis was made in the OPD of Regional Ayurveda Research Institute for Drug Development (RARIDD) Gwalior and then confirmed with the help of X-ray and pathological examination. After confirmation of allergic rhinitis on basis of increased absolute eosinophil count, patient was considered for this case study. This case of allergic rhinitis with elevated absolute eosinophil count was managed by Ayurvedic Intervention of MallaSindoor 125 mg and ShringBhasma 250 mg thrice a day with Honey for 17 days at the outpatient department level. Result: The response of the treatment was found highly significant by symptomatic and pathological investigation. At the end of treatment period of 17 days as compared with baseline, a significant change in clinical symptoms was observed and significant reduction in AEC. Conclusion: MallaSindoor and ShringBhasmaadministered together in above-mentioned dose were found very effective and safe in patient of allergic rhinitis with increased absolute eosinophil count.


  1. AjithKumar.C.S Predictive value of absolute Eosinophil count for Bronchial Hyper reactivity in allergic rhinitis: Indian Journal of Basic & Applied Medical Research; March 2013: Issue-6, Vol.-2, P. 623-628
  2. Brutsche MH, Downs SH, Schindler C, GerbaseMW,Schwartz J, Frey M, Russi EW, Ackermann-Liebrich U, Leuenberger P. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax 2006;61:671?677.
  3. Xu X, Rijcken B, Schouten JP, Weiss ST. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997;350:1431?1434.
  4. Horn BR, Robin ED, Theodore J, Van Kessel A. Total eosinophil counts in the management of bronchial asthma. N EngI J Med 1975;292:1152-5.
  5. Anand K. Patel, Tapan P. NagpalComparison of blood absolute eosinophil count and nasal smear eosinophils with symptoms and severity of clinical score in patients of allergic rhinitis : Indian Journal of Allergy, Asthma and Immunology | Jul-Dec 2014 ? Volume 28 ? Issue 2
  6. Bachert C. Persistent rhinitis ? Allergic or non allergic? Allergy 2004;59:11‑
  7. Rocchiccioli K, Pickering CAC, Cole M, HorsfieldN.Effect of regular treatment with sodium cromoglycateon non-specific bronchial hyperreactivity [Abstract].Thorax 1984;39:706.
  8. Aubier M, Levy J, Clerici C, Neukirch F, Herman D. Different effects of nasal and bronchial
  9. glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992;146:122?126
  10. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy ClinImmunol 1992;90:250?256.
  11. Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy ClinImmunol 1993;91:97?101.
  12. Allergic Rhinitis: Causes, Remedies, Ayurvedic treatment, Herbs: available from http://easyayurveda.com/2016/03/05/allergic-rhinitis-remedies-ayurvedic-treatment-herbs/
  13. Vivek Kumar, B. J. Patgiri, P. K. Prajapati, GalibRuknuddin, Standard manufacturing procedure of MallaSindura: International Journal of Green Pharmacy, Oct-Dec 2016: 10 (4)? 235
  14. Anonymous, the Ayurvedic Formulary of India, Part ?I, First edition, Ministry of Health and family Planning, Government of Indian, New Delhi, 1978.
  15. Swami SadasivaTirta, the ayurvedicEncyclopaedia, First Edition, Indian Books Centre, New Delhi, 1998.
  16. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy ClinImmunol 2001;108:S147?S334.
  17. Jagdeeshwar K, Venumadhav V, Chowdary S, Sudharani V, Kumar V. A study on serum IgE levels, peripheral eosinophils and individual symptoms in patients with non infective rhinitis and asthma and related conditions. Int J Pharm PharmSci 2012;4:88‑
  18. AmitNaphade, GurucharanBhuyan, PSC Murty: A Clinical study to Assess the efficacy of Malla-Sindoor for the Management of Pakshaghat (Hemiplagia) JRAS Vol. XXXII, No. 3-4, July-Dec. 11, pp 67-78.
  19. Anupama, MallaSindoor Benefits, Ingredients, Dosage: available from https://www.bimbima.com/ayurveda/malla-sindoor-benefits-ingredients-dosage/432/ ?September 18, 2014.
  20. Rajasekaran, S. Murugesan: Stansardisation of SringaBhasma, Ancient Science of Life Vol.No. XXI (3) January 2002 ,pp 167-169
  21. Jagdev Singh ShringBhasma, Ayur times available from https://www.ayurtimes.com/shringa-bhasma/ Updated April 11, 2017.
?

[Bharati P.L, Agarwal Prateek, Sharma Rashmi, Subhose V. and Jadhav A. D. (2017); A CASE STUDY ON THE THERAPEUTIC EFFECT OF MALLA SINDOOR AND SHRING BHASMA IN THE ELEVATED ABSOLUTE EOSINOPHIL COUNT. Int. J. of Adv. Res. 5 (Oct). 1872-1875] (ISSN 2320-5407). www.journalijar.com


Dr.P.L.Bharati
Research Officer (Scientist-2), Regional Ayurveda Research Institute for Drug Development, Aamkho, Gwalior (M.P.)

DOI:


Article DOI: 10.21474/IJAR01/5713      
DOI URL: https://dx.doi.org/10.21474/IJAR01/5713